Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check7 days agoChange DetectedThe Record History now includes a new revision tag v3.5.4. The previous revision v3.5.3 is removed from the history list.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThis update reflects a change to the site’s interface/version label (revision v3.5.3 instead of v3.5.2) without altering the underlying clinical trial record history content.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a new revision entry v3.5.2 and removed the v3.5.0 entry from the history.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.5.0 replaces Revision: v3.4.3 in the record history.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check101 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice and the Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.